510(k) · Cleared

Cleared

Vantage Pro Attenuation Correction Device

K033735510(k) TraditionalCleared Dec 12, 200314-day reviewClass II21 CFR 892.1200

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Adac Laboratories · KPS System, Tomography, Computed, Emission

Cleared on Dec 12, 2003 as substantially equivalent to K992078 (Adac Laboratories, 1999) after a 14-day review. Its family tree reaches back 3 generations to 1995.

Decided: Dec 12, 2003
Review: 14 days
Class: Class II
Product code: KPS
Recalls: None
Predicates: 1

Its longest line of descent runs back 3 generations to K943596 (1995). No later device cites it as a predicate yet.

By dateBy generation

Root · 3 generations backK943596 Vantage, for Adac Gamma CamerasAdac Laboratories · 1995
2 generations backK971878 Vantage 2.1 ExspectAdac Laboratories · 1997
1 generation backK992078 Vantage Exspect IIAdac Laboratories · 1999
This deviceK033735 Vantage Pro Attenuation Correction DeviceAdac Laboratories · 2003

View FIG. 1 as a table

Line of descent and top descendants

Generation	Number	Device	Applicant	Decided	Recalls
−3	K943596	Vantage, for Adac Gamma Cameras	Adac Laboratories	1995	—
−2	K971878	Vantage 2.1 Exspect	Adac Laboratories	1997	—
−1	K992078	Vantage Exspect II	Adac Laboratories	1999	—
0 (this device)	K033735	Vantage Pro Attenuation Correction Device	Adac Laboratories	2003	—

FIG. 1 — Lineage of K033735, 1995–2003Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KPS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KPS device

#1 K253564 uMI Panvivo (uMI Panvivo); uMI Panvivo (uMI…score 18.6 · 17 generations · no Class I recall
#2 Held for the reportin the report
#3 Held for the reportin the report

Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

Type	Number	Device	Applicant	Decided	Recalls
*	K992078	Vantage Exspect II Summary page 1 …Product Code: 90 KPS C. Date prepared: November 12, 2003 D. Predicate Device: Vantage ExSPECT II (K992078) E. Intended Use: The Vantage Pro Attenuation Correction Device option to gamma camera systems…	Adac Laboratories	1999	—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

The line of descent spans 8 years and passes through 1 company; a new generation was cleared every 2.3 years on median.
None of the 3 ancestors has a recall.

How does its category compare?

All KPS devices

KPS System, Tomography, Computed, Emission: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · KPS

12in 2025

2007high 17 (2008) · low 3 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KPS

65in 2025

2007high 112 (2015) · low 25 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KPS

16in 2025

2007high 34 (2011) · low 4 (2010)2026

Class I (17 since 2007) Class II/III not classified

Adverse event reports per year · KPS

36in 2025

2007high 240 (2013) · low 10 (2016)2025

MAUDE reports naming product code KPS, not matched to any one device; reports are not rates.

View these four charts as a table

Year	Decisions	Median 510(k) review, days	Recalls (Class I)	MAUDE reports
2007	8	38	22	38
2008	17	25	16	11
2009	9	42	14	15
2010	3	91	4	44
2011	7	28	34	56
2012	6	94	13	34
2013	11	84	13	240
2014	11	92	18	33
2015	3	112	5	24
2016	11	65	16	10
2017	11	104	11	31
2018	13	59	12 (3)	26
2019	3	60	5 (5)	105
2020	12	72	8	22
2021	15	66	4	10
2022	5	60	8 (6)	15
2023	12	63	6 (3)	22
2024	11	59	15	23
2025	12	65	16	36
2026	6	67	6	—

What is it indicated for?

The Vantage Pro Attenuation Correction Device option to gamma camera systems marketed by ADAC, a Philips Medical Systems Company, produces images that depict the anatomical density of a patient. The system is intended to provide an enhancement to the emission images acquired using the gamma camera system by correcting for attenuation effects in the patient. Vantage Pro includes additional quality assurance tools to evaluate the resulting density image.

Indications for use as stated in the FDA summary.

https://510kreport.com/device/K033735 · printed Nov 6, 2026

Cite this page

510(k) Report. “K033735: Vantage Pro Attenuation Correction Device.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K033735

Report an extraction error

Are you the manufacturer?

Record history

FDA decision record loaded May 2, 2026
Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
Lineage and recalls computed Nov 3, 2026
Page last updated Nov 3, 2026